Evidence map›Paper›PMID 42403491›Full record

ArticleJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2026

Adherence to cervical screening and follow-up care in HIV-positive women at a Canadian tertiary care centre.

Rachel Foote, Julia Julkipli, Alhanouf Alanazi, Ahmed Bishara, Noor BuMurah, Nor Azmaniza Azizam, Janica Adams, Michael Silverman, MohammadReza Rahimi Shahmirzadi

Abstract read
In one paragraph

Article in Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rachel FooteDepartment of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Julia JulkipliDivision of Infectious Diseases, Western University, London, Ontario, Canada.
Alhanouf AlanaziDivision of Infectious Diseases, Western University, London, Ontario, Canada.
Ahmed BisharaDivision of Infectious Diseases, Western University, London, Ontario, Canada.
Noor BuMurahDivision of Infectious Diseases, Western University, London, Ontario, Canada.
Nor Azmaniza AzizamFaculty of Business and Management, Universiti Teknologi MARA Selangor, Puncak Alam Campus, Selangor, Malaysia.
Janica AdamsSt. Joseph's Healthcare London, Department of Medicine, Division of Infectious Diseases, London, Ontario, Canada.
Michael SilvermanDivision of Infectious Diseases, Western University, London, Ontario, Canada.ORCID https://orcid.org/0000-0002-0389-7656
MohammadReza Rahimi ShahmirzadiDivision of Infectious Diseases, Western University, London, Ontario, Canada.ORCID https://orcid.org/0000-0002-2410-6788

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Women with HIV are at a significantly increased risk of developing cervical cancer. However, adherence to cervical screening guidelines remains suboptimal.The objective was to assess adherence to Pap test initial screening and follow-up at St. Joseph's Hospital (SJH) in London, Ontario, and to analyze their association with sociodemographic characteristics. Methods: A retrospective cohort study was conducted of women with HIV ≥21 years of age who were attending SJH's HIV clinic between 2015 and 2024. Medical records were reviewed to determine Pap test completion at HIV diagnosis, follow-up adherence, and management of abnormal results. Results: Of 235 women identified, 211 were included. Only 29% (n = 62) underwent Pap testing at the time of HIV diagnosis. Among 148 women with normal initial cytology, only 28 (19%) completed three consecutive annual follow-up screenings. Thirty-four women (17%) had atypical squamous cells of undetermined significance (ASC-US) results, of whom 29 (85%) underwent appropriate repeat cytology within 6 to 12 months. Fifty-three women (27%) were diagnosed with low-grade squamous intraepithelial lesion (LSIL) or higher-grade lesions, and 42 (79%) were appropriately referred for colposcopy. Adherence to cervical screening was positively associated with year of HIV diagnosis ( Conclusions: Substantial gaps exist in cervical cancer screening and follow-up among women with HIV. Despite guideline recommendations, less than one-third of patients in our cohort received Pap test at the time of HIV diagnosis, and long-term follow-up adherence was low. Enhanced system-based interventions are required to improve screening continuity and outcomes in this high-risk population.

Indexed as

cervical cancercervical screeningHIVPap testscreening adherencewomen's health

Identifiers

PMID42403491
PMCPMC13331607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.